Exact Sciences Corporation (Exact) is a molecular diagnostics company focused on the early detection and prevention of colorectal cancer. The Company's non-invasive stool-based deoxyribonucleic acid (sDNA) screening technology includes methods that isolate and analyze human DNA present in stool to screen for the presence of colorectal pre-cancer and cancer. The Company has an intellectual property protecting its non-invasive, molecular screening technology for the detection of colorectal pre-cancer and cancer. The Company?s Cologuard test includes DNA markers. In addition to DNA markers, its test will also include a protein marker to detect blood in the stool, utilizing an antibody-based fecal immunochemical test (FIT). Its Cologuard test is designed to detect pre-cancerous lesions or poly... (Source: SEC reports)
Competitor - 1/8
Which company is more competitive with Exact Sciences?
MADISON, Wis., March 20, 2018 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS), the company that developed and commercialized CologuardÂ®, the only FDA-approved, noninvasive stool DNA-based test for early [...]
MADISON, Wis., June 22, 2017 /PRNewswire/ --Â Exact Sciences today announced it is teaming up with Madison professional golfer Jerry Kelly to help drive home the importance of colorectal cancer screening.Â [...]